Month: January 2021

2024.07.17
Summary of the most important events and achievements of the Genomtec S.A.

2024.06.25
Webinar: Trends in the M&A Market Specific to In-Vitro Diagnostics | 27 June, 2024, 3:00 p.m. (CEST)

2024.04.22
Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

2024.03.26
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

Archive

2021.01.20

Genomtec diagnostic test SARS-CoV-2 Duo Kit (cat. no. GA00B) detects all published virus variants (British, South African and Brazilian).

Genomtec conducted a detailed analysis of the introduced in each variant mutations, both by a bioinformatics analysis (in-silico) and also in a ...
Read
2021.01.04

Genomtec ID gets third Prize in the Final of 2020 “Maker in China”

Genomtec’s flagship platform, Genomtec ID, has got a third Prize in the Final of 2020 edition “Maker in China” International SME Innovation & ...
Read

Archive